Across TCGA pan-cancer cohorts, LINC00240 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated LINC00240 data layer.
The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC00240 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC00240 expression acts as an unfavorable survival marker, although some lineages such as LUAD and UVM show a favorable association.
LUAD, UVM, and READ are the cancer types where LINC00240 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.